Document is current
Any future updates will be listed below
-
Authors
Vella, Gerlanda
Rescigno, Maria https://orcid.org/0000-0002-6464-509X
-
Funding
Funding for this research was provided by:
European Molecular Biology Organization (ALTF 687-2023)
Fondazione AIRC per la ricerca sul cancro ETS (AIRC 5x1000 22757)
Fondazione AIRC per la ricerca sul cancro ETS (IG 28930-2023)
- License Information
-
More Information
Article History
Received: 31 January 2025
Revised: 28 April 2025
Accepted: 13 May 2025
First Online: 28 May 2025
Disclosure and competing interests statement
: MR is the founder and CSO of Postbiotica srl.
